Valuation Polaryx Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-20 EDT			5-day change	1st Jan Change
1.910 ^USD	-0.52%		-1.55%	-

09-01	Polaryx Therapeutics, Inc. Announces Appointment of Dr. Will Charlton as Chief Medical Officer,Effective September 1, 2026	CI
08-25	Polaryx Therapeutics, Inc. Advances Operational Readiness for SOTERIA Phase 2 Basket Trial	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	95.21	-	-
Change	-	-	-
Enterprise Value (EV)	95.21	95.21	95.21
Change	-	0%	0%
P/E	-9.79x	-6.64x	-5.36x
PBR	-	-	-
PEG	3.92x	-0.1x	-0.2x
Capitalization / Revenue	-	-	-
EV / Revenue	-	-	-
EV / EBITDA	-	-	-
EV / EBIT	-11.3x	-5.85x	-4.56x
EV / FCF	-11.8x	-12.5x	-8.07x
FCF Yield	-8.51%	-7.98%	-12.4%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.195	-0.2875	-0.3567
Distribution rate	-	-	-
Net sales ¹	-	-	-
EBITDA	-	-	-
EBIT ¹	-8.435	-16.28	-20.9
Net income ¹	-9.164	-16.42	-22.07
Net Debt	-	-	-
Reference price ²	1.910	1.910	1.910
Nbr of stocks (in thousands)	49,846	-	-
Announcement Date	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
POLARYX THERAPEUTICS, INC.	-9.79x	-	-	-	95.21M
WUXI APPTEC CO., LTD.	19.21x	6.83x	13.69x	1.55%	66.34B
LONZA GROUP AG	36.32x	6.47x	19.31x	0.89%	52.92B
ARGENX SE	29.51x	8.11x	25.65x	0.05%	54.82B
IQVIA HOLDINGS INC.	34.13x	3.33x	14.37x	-.--%	44.09B
BEONE MEDICINES AG	50.62x	5.85x	32.15x	-.--%	43.72B
REVOLUTION MEDICINES, INC.	-20.41x	209.35x	-21.69x	-.--%	42.13B
CELLTRION, INC.	29.48x	8.35x	21.6x	0.36%	33.96B
WUXI BIOLOGICS (CAYMAN) INC.	30.25x	6.41x	16.63x	-.--%	26.17B
GENMAB A/S	31.94x	5.89x	19.81x	-.--%	23.37B
Average	23.12x	28.95x	15.73x	0.32%	38.76B
Weighted average by Cap.	26.34x	28.52x	15.73x	0.42%